Recently, results of several large randomized trials have shown a reduction in mortality in acute myocardial infarction (MI) with the early use of thrombolytic agents.'-* Despite the reduction in mortality observed with thrombolytic therapy, the incidence of reinfarction or recurrent ischemic events is increased.1*2,5 Acute angiographic studies have shown that after successful thrombolysis, there is a high-grade residual coronary stenosis in most patients.6 Emergent percutaneous transluminal coronary angioplasty (PTCA) has the potential to reduce infarct vessel stenosis and may prevent recurrent ischemia.7r8
With the likelihood of wide-scale use of intravenous thrombolysis, it will become increasingly important to select those patients who need early definitive revascularization.
The present study was undertaken to define whether there are arteriographic predictors of adverse clinical outcome and early reocclusion of infarct vessel.
METHODS

Study
design.
The study design has been described previously.g Briefly, 50 consecutive patients with acute MI, who were initially seen within 6 hours of onset of symptoms were randomly assigned on a 3:l basis to groups receiving either intravenous recombinant tissue plasminogen activator (t-PA), 1.25 mg/kg over 3 hours, or placebo.
Coronary angiography was performed at 60,90, and 120 minutes after the infusion was started. The final infarct vessel patency determination was made at 120 minutes according to the Thrombolysis in Myocardial Infarction (TIMI) study classificationlo. Infarct vessels showing TIM1 2 or 3 flow patterns were considered to be patent. If residual stenosis X0% was present in a patent vessel, these patients were randomly assigned to either emergent PTCA or no PTCA. Patients with significant disease of A submaximal stress test with thallium-201 tomographic imaging was performed before discharge (3 to 10 days after infarction).
The patients' cardiac medications were not discontinued for the study. Upright treadmill exercise was performed in 3-minute uninterrupted stages with a constant speed of 2 miles/hr and a 3% grade increment for each stage. Complete 12-lead ECGs were obtained at rest and at the end of each stage of exercise. Thallium-201 chloride (3 mCi) was injected intravenously at peak exercise and exercise was continued for one additional minute. Tomographic gamma camera imaging was then performed immediately with delayed views obtained 3 hours later. Exercise was terminated when one of the following conditions occurred: a target heart rate of 130 bpm, angina, marked ST segment depression, hypotension, serious ventricular arrhythmia, or exhaustion.
The ECG was interpreted as positive for ischemia when the patient developed 2 mm or more of horizontal ST segment depression compared to the baseline tracing.
Scintigraphic imaging was performed by means of a wide-field-of-view gamma camera (GE 400AT) equipped with a general-purpose, parallel-hole collimator. Image data were acquired in 64 projections over a 180-degree arc beginning with the right anterior oblique and ending with the left posterior oblique position. Images were obtained in a 64 X 64 word mode image with 30,000 to 50,000 counts/image.
Total acquisition time was approximately 20 minutes. Tomographic reconstruction was then performed by means of a commercial convolution/back projection algorithm (GE STAR, General Electric, Milwaukee, Wise.) without attenuation correction. The reconstructed image data were reformatted to produce vertical, horizontal long-axis, and short-axis planes of section. Comparable images were obtained at the 3-hour imaging session. An image defect was considered present if there was a discrete region of absent or decreased activity estimated visually. The defect was anatomically localized as apical, anterior, septal, inferior, or lateral with t.he use of all sections. A defect present immediately after exercise and again at 3 hours' delay was considered to be indicative of infarction, whereas a defect present only immediately after exercise was considered to reflect isdhemia. Either partial or complete resolution of a defect was considered evidence of reversible ischemia. If the reversible defect occurred adjacent to the zone of infarction, it was considered to represent periinfarct ischemia; if it occurred at a site removed from the zone of infarction, it was considered to represent distant ischemia.
Statistical
evaluation.
Data are presented as mean +-1 standard deviation unless otherwise stipulated. Student's t and Fisher exact tests were used for statistical analysis where appropriate. Differences were considered significant at the p < 0.05 level.
Clinical outcomes.
Patients were monitored throughout their hospitalization for the following clinical events: (1) death; (2) postinfarction angina-recurrent chest pain at rest with accompanying ECG changes i.n the infarct territory; (3) reinfarction-prolonged chest discomfort with attendant enzymatic confirmation of creatine kinase-MB elevation; (4) exercise-induced ischemia-submaximal exercise testing before discharge demonstrating reversible thallium-201 uptake in the region of the infarct zone. Reversible defects in the noninfarct zones were excluded. Subjects who required additional revascularization procedures before exercise testing were also excluded. Clinical events were coded by investigators who were blinded to the results of coronary angiographic analysis.
Patients were considered to have reached a clinical end point if there was a recurrence of ischemia, at which time such patients were considered for revascularization with coronary angioplasty or coronary artery bypass surgery.
RESULTS
Angiographic results.
Demographic and clinical data for the 50 patients have been previously reported.g The results of infarct vessel patency are as follows: two of the 12 patients who received placebo (17 % ) showed infarct vessel patency. Eleven of these patients underwent PTCA, which was successful in nine. Of the 38 patients receiving t-PA, 71% had a patent infarct vessel at 90 minutes and by 120 minutes, 32 of 38 patients (84 % ) had a patent vessel. It is noteworthy that five of these patients showed intermittent patency and occlusion during serial angiography. At six patients with failed t-PA thrombolysis underwent PTCA, flow was successfully reestablised in four. Of the 32 patients with successful t-PA thrombolysis, one underwent emergency bypass surgery because of left main coronary artery disease and three had 60% residual stenosis of the infarct vessel.. Of the 28 patients with high-grade stenoses after thrombolysis, 13 were randomly assigned to no PTCA and 15 were randomly assigned to immediate PTCA. All angioplasties in this group were successful with the mean stenosis decreasing from 80.8 + 8.2% to 32.5 ? 15%. With the addition of PTCA in patients with occluded vessels, overall patency was increased to 92 % .
Hospital course. Cardiac complications including death or spontaneous or provocable ischemia occurred in 21 patients. Fig. 1 shows the spectrum of severity of infarct vessel residual stenosis after acute High-grade residual stenosis, defined as more than 50% diameter narrowing, was present in 23 patients. This group comprised four patients with unsuccessful recanalization, four who underwent PTCA that was initially thought to be successful but who were later found to have 250% stenosis by quantitative arteriography, and 15 who did not undergo PTCA. Of the 27 patients with residual stenosis of less than 50%) 25 underwent PTCA to reduce the stenosis; the remaining two patients had insignificant stenosis remaining after thrombolysis alone. There were no statistical differences in sex, age, time to reperfusion, location of infarct vessel, or presence of multivessel disease between the two groups (Table I) . Table II describes the incidence of in-hospital death or ischemia in the two groups: ~50% or <50% residual stenosis. There were four deaths in the trial. All four deaths occurred in patients with high-grade residual stenosis 0, < 0.001); three of these patients had undergone unsuccessful reperfusion. The infarct-related artery was the right coronary in two and left anterior descending in two. Two of these patients had received placebo, recanalization did not occur spontaneously, and angioplasty was unsuccessful in achieving sustained patency. One patient failed t-PA thrombolysis and had only brief reperfusion after PTCA before the artery reoccluded in the laboratory. The other death was in a 73-year-old man who received t-PA (5.2 hours after the onset of chest pain) and emergent angioplasty (at 7.5 hours) but had a very extensive anterior infarction. Although PTCA was initially thought to be successful, subsequent analysis showed 55% residual stenosis with TIM1 2 flow, thrombus, and arterial dissection. All four patients developed cardiogenic shock and recurrent ventricular tachycardia and fibrillation before death. In addition to death, other adverse in-hospital clinical events were associated with high-grade residual stenosis (Fig. I) . Three of 19 (16%) survivors with residual stenosis >50% had in-hospital reinfarction but only 1 of 27 survivors (4%) with minor residual obstruction (p = 0.15). Postinfarction angina occurred in 8 of the 19 (42%) survivors with high-grade stenosis compared to only four (15%) patients with <SO% residual stenosis (p < 0.05). Of the 14 patients with high-grade residual stenosis of the infarct artery who underwent exercise tomographic thallium scintigraphy, seven (50%) showed evidence of periinfarct ischemia. Only one patient had ECG changes diagnostic of ischemia, the remaining ECGs could not be interpreted because of changes at baseline. Of the 23 patients with minor residual stenosis who underwent exercise testing, none had provocable ischemia (p < 0.001).
Cardiac complications, including postinfarction angina, recurrent infarction, exercise-induced ischemia, or death, were observed in 74 % of patients with residual stenosis >50% vs 15% of the group with <50% stenosis (p < 0.001).
The need for delayed revascularization of the infarct artery was also determined for the two groups (Fig. 2) . Fifty-three percent of survivors with Fig. 3 . Cumulative patient events including death, reinfarction, and spontaneous or provocable ischemia for two groups: ~50% and <50%. Late revascularization with bypass surgery or PTCA was performed for recurrent ischemia in 53% of survivors with ~50% stenosis.
residual stenosis of the infarct artery 2'50% underwent late revascularization with either angioplasty or bypass surgery. Each patient received the additional intervention for spontaneous or exerciseinduced ischemia as previously defined. This 53% incidence of late revascularization for patients with high-grade residual lesions compares to only 4% in the group with <50% stenosis (p < 0.001).
Reocclusion.
Of the 46 patients with successful recanalization, 44 had follow-up coronary arteriography. In 10 patients the infarct artery was reoceluded at follow-up, which represents an incidence of 23%.
Several angiographic features of the infarct artery at the completion of the acute intervention were evaluated to determine the relationship to early reocclusion. Time to reperfusion, location of infarct vessel, presence of thrombus or dissection, use of t-PA or placebo, use of PTCA, and successful vs unsuccessful t-PA thrombolysis were all considered and found not to be significantly different between patent and reoccluded groups. High-grade residual stenosis of the infarct artery was present in 50% of the vessels that reoccluded but not significantly different from those who remained patent (41%). Only 26% of vessels with residual stenosis of >50% were reoccluded at follow-up. TIM1 2 (suboptimal) flow was present in 30% of those v8essels that reoccluded, and its presence was associated with a 50% reocclusion rate compared to a rate of only 18% in those vessels with TIM1 3 flow (p = 0.09). Intermittent patency was present in onl,y five arteries and was associated with unsuccessful reperfusion in two. The three arteries with successful recanalization but intermittent patency during the acute procedure all were found to be reoccluded at follow-up catheterization (Fig. 3) . It is noteworthy that 90% of all reocclusions were associated with at least one of three angiographic features of infarct artery: high-grade residual stenosis, TIM1 2 flow, or intermittent patency during acute intervention.
Absence of these risk factors predicted a 95% patency rate at follow-up.
In five patients, reocclusion was associated with chest pain and ECG changes. In three of these five patients, symptomatic reocclusion occurred within 24 hours after initial therapy. Reocclusion was silent in the remaining five patients. It should be noted that four of these five patients with silent reocclusion had well-developed collateral arteries to the infarct-related artery and one demonstrated periinfarct ischemia by exercise thallium. Our results confirm the high incidence of reocclusion and recurrent ischemia after reperfusion therapy for acute MI. Use of intravenous t-PA, PTCA, or both may achieve high infarct vessel patency rates (92 % ). Despite this high initial patency rate, a significant number of these patients (17 of 50) had recurrent ischemia or died during hospitalization. Eighty-five percent of patients with an in-hospital cardiac event had residual stenosis of the infarct artery ~50%. These patients had either not undergone PTCA or bad a suboptimal result of angioplasty.
Post-infarction angina occurred spontaneously in 42 % of survivors with high-grade stenosis. Exerciseinduced periinfarct ischemia by thallium scintigraphy was present in 50% of those with infarct vessel stenosis > 50 % .
The high incidence of exercise-induced ischemia in this study may be related to enhanced myocardial salvage or greater sensitivity.of tomographic thallium scintigraphy.
Only one of seven patients with periinfarct ischemia by thallium developed ischemic ECG changes with exercise. It is known that stress ECG is not a sensitive measure of ischemia in the setting of baseline ST segment changes or Q waves.12 The sensitivity of thallium imaging after infarction is greater than stress ECG alone and a positive result has been shown to have poor prognostic implications.13
All deaths occurred in patients with high-grade residual stenosis; three of these four patients had unsuccessful reperfusion. Other investigators have also found a higher mortality rate in patients with an occluded infarct vesse1.14-16 Although the numbers are small, the lack of mortality among patients with a widely patent infarct vessel after t-PA and angioplasty is noteworthy. Spontaneous or provocable ischemia prompted delayed in-hospital revascularization with PTCA or bypass grafting in 53 % of survivors with high-grade infarct vessel stenosis. This finding underscores the importance of a high-grade lesion of the infarct vessel for instability.
Predictors of reocclusion.
Coronary arterial reocelusion remains a significant problem after successful thrombolytic therapy. Recent studies have shown that after successful thrombolysis by means of 90-to 180-minute infusions of t-PA, early reocclusion occurs in 33 % to 45 % of infarct arteries.", l8 With prolonged (6-to g-hour) infusions of t-PA in a larger trial of 386 patients, the combined incidence of reocclusion and recurrent ischemic events was less than 20% .I9 In the present study, the relatively high incidence of reocclusion and recurrent ischemic events probably relates to the lower total dose of t-PA and the shorter duration of infusion used. Suboptimal (TIM1 2) flow was associated with a higher rate of reocclusion, which may have resulted from the increased likelihood of rethrombosis in a diminished flow state. An interesting finding was that of intermittent patency of the infarct artery observed between the 60-, 90-, and 120-minute angiograms. This finding was observed in five arteries, two which failed reperfusion despite t-PA and PTCA, and the remaining three vessels reoccluded. Therefore, intermittent patency during infusion of Four of five "silent" reocclusions occurred in patients with well-developed collateral arteries completely filling the infarct artery at the time of follow-up catheterization.
One of these patients showed periinfarct redistribution on exercise thallium scintigraphy. This data would suggest that "silent" reocclusions are not always the result of lack of viable myocardium perfused by the infarct vessel. The development of collateral arteries may have protected these patients from reinfarction or perhaps denervation of the infarct area prevents clinically recognized angina. Silent ischemia may, in fact, be more common after acute MI.21*22
Limitations.
The results are from a relatively small population of patients who underwent acute intervention; thus, they must be interpreted with caution. A patient with total occlusion of the infarct artery may have a particularly poor prognosis compared to a patient with partial reperfusion.23 Thus, inclusion of patients with total (100 % ) occlusion in the group with ~50% residual stenosis in our study may represent a particularly skewed group with respect to negative clinical outcome. However, only 4 of 50 patients bad unsuccessful reperfusion. Three of the four deaths occurred in patients with 100% occlusion. The remaining patient with unsuccessfu reperfusion had no in-hospital cardiac complications.
The need for delayed revascularization was determined by recurrent ischemic events. However, despite documented ischemia in three patients with <50 % residual stenosis, revascularization was only performed in one. In many cases the requirement for delayed PTCA or bypass surgery may have been the presence of high-grade stenosis.
implications.
These data identify patientsat high risk for reocclusion of the infarct artery after t-PA infusion, PTCA, or both. Patients with suboptimal (TIM1 2) flow or intermittent patency during infusion of t-PA had the highest rate of reocclusion. The inability to achieve sustained arterial patency despite the use of t-PA and PTCA suggests that other measures, including coronary bypass surgery, nonselective thrombolytic agents, or coronary stems, need to be evaluated in patients at high risk of reocclusion. After therapy with t-PA or angioplas-ty, a vessel with residual stenosis of ~50% is associated with an increased risk of death, recurrent ischemic events, and the need for subsequent revascularization. This suggests that PTCA, if performed, should ideally reduce the stenosis of the infarct artery to <50%.
